Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-11-05

FDA Approved: LEVOXYL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

The FDA approved a supplemental application for LEVOXYL (levothyroxine sodium) from Pfizer Laboratories Div Pfizer Inc. This action updates the product labeling…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVOXYL (LEVOTHYROXINE SODIUM)

Snippet

SUPPL AP for LEVOXYL (LEVOTHYROXINE SODIUM)